<DOC>
	<DOCNO>NCT01160068</DOCNO>
	<brief_summary>To compare single dose bioavailability Metformin Hydrochloride 1000 mg tablet ( Dr. Reddy 's Laboratories Ltd. , Generics , India ) Glucophage ( Metformin Hydrochloride ) 1000 mg tablet ( Bristol-Myers Squibb , USA ) 48 + ( 2 standby ) healthy , adult , human subject feed condition . To monitor adverse event ensure safety subject .</brief_summary>
	<brief_title>Bioequivalence Study Metformin Hydrochloride Tablets 1000 mg Tablets Dr. Reddy 's Laboratories Limited Under Fed Condition</brief_title>
	<detailed_description>Open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover bioequivalence study least 07 day washout period drug administration feed condition .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subjects provide write informed consent . Subjects healthy within 1845 year age ( inclusive ) weigh least 50 kg . Subjects within ±10 % ideal body weight relation height accord Life Insurance Corporation India heightweight chart nonmedical case . Subjects normal health determine medical history physical examination perform within 15 day prior commencement study . Subjects normal ECG , Xray vital sign . Availability subject entire study period willingness adhere protocol requirement evidence write informed consent If subject female volunteer child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) Subjects incapable understanding informed consent . Subjects BP : ≤90/60 BP≥140/90 . History hypersensitivity idiosyncratic reaction Metformin Biguanides . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal , endocrine , immunologic , neurologic haematologic function . Regular smoker smoke ten cigarette daily difficulty abstain smoke duration study period . Subjects take counter prescribed medication , include enzyme modifying drug systemic medication within past 30 day prior start clinical period . History psychiatric illness , may impair ability provide write , informed consent . Subjects history alcohol substance abuse within last 5 year . Subjects clinically significant abnormal value laboratory parameter . Subjects participate clinical investigation use experimental drug bleed 350 mL past 3 month . Subjects test positive screening HIV , HbsAg HCV Subjects positive urine drug screen test drug abuse . Any subject Metformin contraindicate medical reason . Subjects use drug substance herbal preparation know strong inhibitor CYP enzyme ( formerly know cytochrome P450 enzyme ) within 14 day prior first dose . Female volunteer demonstrate positive pregnancy screen . Female volunteer currently breastfeed .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2005</verification_date>
</DOC>